1.
Cardiovascular Toxicity of Nicotine: Implications for Electronic Cigarette Use
by Benowitz, Neal L
Trends in cardiovascular medicine, 2016, Vol.26 (6), p.515-523
2.
Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participan...
by Lorenz, Matthias W, Dr
The Lancet (British edition), 2012, Vol.379 (9831), p.2053-2062
3.
Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study
by Dehghan, Mahshid
The Lancet (British edition), 2017-11-04, Vol.390 (10107), p.2050-2062
4.
Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study
by Leong, Darryl P, Dr
The Lancet (British edition), 2015, Vol.386 (9990), p.266-273
5.
Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people
by Rapsomaniki, Eleni, Dr
The Lancet (British edition), 2014, Vol.383 (9932), p.1899-1911
6.
Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study
by Tawakol, Ahmed, Dr
The Lancet (British edition), 2017, Vol.389 (10071), p.834-845
7.
The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective
by Mahmood, Syed S, MD
The Lancet (British edition), 2014, Vol.383 (9921), p.999-1008
8.
The role of uric acid in the pathogenesis of human cardiovascular disease
by Kanbay, Mehmet
Heart (British Cardiac Society), 2013-06, Vol.99 (11), p.759-766
9.
Understanding the rise of cardiometabolic diseases in low- and middle-income countries
by Miranda, J Jaime
Nature medicine, 2019-11, Vol.25 (11), p.1667-1679
10.
Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease
by Lees, Jennifer S
Nature medicine, 2019-11, Vol.25 (11), p.1753-1760
11.
Computational fluid dynamics modelling in cardiovascular medicine
by Morris, Paul D
Heart (British Cardiac Society), 2016-01, Vol.102 (1), p.18-28
12.
The epidemiology of cardiovascular disease in the UK 2014
by Bhatnagar, Prachi
Heart (British Cardiac Society), 2015-08, Vol.101 (15), p.1182-1189
13.
Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiologica...
by Yusuf, Salim, Prof
The Lancet (British edition), 2011, Vol.378 (9798), p.1231-1243
14.
Trends in the epidemiology of cardiovascular disease in the UK
by Bhatnagar, Prachi
Heart (British Cardiac Society), 2016-12, Vol.102 (24), p.1945-1952
15.
Bariatric surgery and cardiovascular outcomes: a systematic review
by Vest, Amanda R
Heart, 2012-12, Vol.98 (24), p.1763-171
16.
Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality
by Pavo, Noemi
Heart (British Cardiac Society), 2015-12, Vol.101 (23), p.1874-1880
17.
State of the Art Review: Depression, Stress, Anxiety, and Cardiovascular Disease
by Cohen, Beth E
American journal of hypertension, 2015-11, Vol.28 (11), p.1295-1302
18.
Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers
by Mars, Nina
Nature medicine, 2020-04, Vol.26 (4), p.549-557
19.
HDL and cardiovascular disease
by Rader, Daniel J, Prof
The Lancet (British edition), 2014, Vol.384 (9943), p.618-625
20.
Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial
by Sabatine, Marc S., MD, MPH
The American heart journal, 2015, Vol.173, p.94-101
